SUNPHARMA has seen a sharp fall from ₹1740 to ₹1580, staying below all key moving averages, indicating weakness. MACD and Parabolic SAR remain bearish, while RSI at 36 signals it’s near oversold, hinting at a possible brief bounce. Support is at ₹1560–₹1550 and ₹1520, with resistance at ₹1660–₹1700.
BUY : SUNPHARMA-EQ( SUNPHARMA ) [3351]
—
by